Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001213900-25-001826
Filing Date
2025-01-08
Accepted
2025-01-08 09:00:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT ea0227128-424b5_citius.htm 424B5 365130
2 GRAPHIC image_001.jpg GRAPHIC 14143
  Complete submission text file 0001213900-25-001826.txt   385971
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-277319 | Film No.: 25516711
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)